Exact Sciences Corporation (EXAS) Reports Q1 Loss of 8c, Beats by a Penny
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Exact Sciences Corporation (NASDAQ: EXAS) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.12 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Stantec (STN) Tops Q2 EPS by 47c
- JD.com (JD) Tops Q1 EPS by 66c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
